Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally.
Jazz Pharmaceuticals stock last closed at $116.96, up 0.47% from the previous day, and has increased 5.61% in one year. It has overperformed other stocks in the Biotechnology industry by 0.82 percentage points. Jazz Pharmaceuticals stock is currently +22.48% from its 52-week low of $95.49, and -21% from its 52-week high of $148.06.
There are currently 60.73M JAZZ shares outstanding. The market capitalization of JAZZ is $7.10B. In the last 24 hours, 1.13M JAZZ shares were traded.
How to Buy Jazz Pharmaceuticals Stock
Not sure how to invest in Jazz Pharmaceuticals stock? Here's how.
Figure out where to buy Jazz Pharmaceuticals stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you determine where to buy Jazz Pharmaceuticals stock.
Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
Deposit funds into your brokerage account: Select your payment method and add your information.
Analyze Jazz Pharmaceuticals stock: The Jazz Pharmaceuticals ticker symbol is JAZZ. Is Jazz Pharmaceuticals stock a good investment? Should you buy shares of JAZZ? How do JAZZ's underlying business fundamentals look? Do top analysts think Jazz Pharmaceuticals is a good buy? Why has JAZZ's stock price moved recently? (Hint: Our stock research tools can help you understand if JAZZ is a good stock to buy).
Place your JAZZ buy order: Decide if you will purchase JAZZ shares at the current market price or use a limit order to buy JAZZ shares at a specific price.
Get updates on your JAZZ position: Create a watchlist to important updates regarding your new investment in Jazz Pharmaceuticals stock.
Step 1: Figure out where to buy Jazz Pharmaceuticals stock
You will need an online brokerage account in order to access the NASDAQ market and buy JAZZ stock.
A brokerage account is an investment account that enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our research, eToro is the best place to buy stocks. eToro gives you:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to global financial markets: From Technology to Financial Services, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've selected your brokerage, it's time to fill out some personal info so you can invest in JAZZ stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Jazz Pharmaceuticals stock
Once you have decided on the best place to buy Jazz Pharmaceuticals stock, it's important to analyze their stock before you invest, so you can wrap your head around the risk and upside.
Jazz Pharmaceuticals stock data
JAZZ Price
$116.96
1w %
12.26%
1y %
5.61%
5y %
6.09%
P/E
12.91x
P/B
1.74x
P/S
1.78x
PEG
0.41x
Revenue
$4.07B
Earnings
$560.12M
Fore. Rev. Growth
5.5%
Fore. Earn. Growth
31.52%
Market Cap
$7.10B
Next Earnings
N/A
Next Dividend
N/A
JAZZ Due Diligence Score
WallStreetZen was designed to help average investors do more accurate fundamental analysis in minutes instead of hours.
JAZZ's operating cash flow of $1.40B allows it to safely service it's debt of $6.15B.
JAZZ profit margin has gone up from 10.8% to 13.8% in the past year.
There are more short-term assets than short-term liabilities on the JAZZ balance sheet.
Failed Financial Due Diligence Checks:
JAZZ has a relatively high debt to equity ratio of 1.93.
There are more long-term liabilities than short-term assets on the JAZZ balance sheet.
JAZZ earnings of $706.79M is not enough to cover its interest payments.
Total JAZZ debt is higher than 5 years ago, relative to shareholder equity.
Is JAZZ stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 12 Equities analysts who track JAZZ, the consensus analyst rating on JAZZ is a Strong Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they investment advice.
Latest JAZZ Analyst Forecasts
Balaji Prasad, a bottom 8% analyst from Barclays maintains JAZZ with a strong buy rating and raises their JAZZ price target from $190.00 to $200.00, on Feb 27, 2025.
Charles Duncan, a top 2% analyst from Cantor Fitzgerald downgrades JAZZ to a hold rating and raises their JAZZ price target from $140.00 to $150.00, on Feb 26, 2025.
David Amsellem, a top 11% analyst from Piper Sandler reiterates JAZZ with a strong buy rating and raises their JAZZ price target from $163.00 to $176.00, on Feb 26, 2025.
Gregory Renza, a top 8% analyst from RBC Capital maintains JAZZ with a buy rating and lowers their JAZZ price target from $179.00 to $178.00, on Feb 26, 2025.
Jessica Fye, a top 5% analyst from JP Morgan maintains JAZZ with a strong buy rating and raises their JAZZ price target from $200.00 to $209.00, on Feb 26, 2025.
Last year, JAZZ earnings were $560.12M. In the last five year, JAZZ's earnings have gone up by -0.35% per year. This was slower than the Biotechnology industry average of 10.4%.
Last year, JAZZ revenue was $4.07B. In the last 5 year, JAZZ's revenue has grown by 13.48% per year. This was slower than the Biotechnology industry average of 45.66%.
No, Jazz Pharmaceuticals doesn't provide an income stream by paying out dividends.
JAZZ Social Trading Data
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your JAZZ buy order
You have two main types of orders:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are mostly the best for newer investors.
Limit order: A limit order is an order to buy or sell a stock at a specific price (or better). If you want to make sure you're buying or selling at an exact price limit, place a limit order.
Press the Open button and your broker will execute the order.
If you require more help with investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Jazz Pharmaceuticals share?
As of Apr 30, 2025, it costs $116.96 to buy one share of Jazz Pharmaceuticals stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.085 shares of JAZZ.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.